Literature DB >> 964572

Kinetics of [14C]cholic acid in fulminant hepatic failure: a prognostic test.

W Horak, R Waldram, I M Murray-Lyon, E Schuster, R Williams.   

Abstract

The kinetics of intravenously injected [14C]cholic acid have been investigated in 14 patients with fulminant hepatic failure, 24 to 36 hr after the development of grade IV encephalopathy. Radioactivity was measured in plasma samples and in the individual plasma bile acid fractions after separation by thin layer chromatography. Plasma disappearance curves of the free [14C]cholic acid were calculated by an iterative nonlinear least squares fitting procedure using a computer. The disappearance of total plasma radioactivity was similar in all patients and greatly prolonged compared with healthy subjects. However, the plasma disappearance of free [14C]cholic acid was significantly faster in the 8 patients who recovered consciousness than in the 6 who did not. Plasma disappearance of free [14C]cholic acid correlated highly significantly with the proportion of conjugated [14C]cholate in plasma. All patients in whom more than 70% of plasma radioactivity was in the conjugated fraction 3 hr after injection survived and left hospital, whereas all of those in whom less than 55% was conjugated died. Measuring the percentage conjugation of [14C]cholate 3 hr after injection may therefore be a useful test of residual liver function in hepatic failure, as a guide to prognosis and in evaluating new forms of treatment.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 964572

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

Review 1.  Serum bile acids in hepatobiliary disease.

Authors:  I A Bouchier; C R Pennington
Journal:  Gut       Date:  1978-06       Impact factor: 23.059

Review 2.  Pathogenesis of hepatic encephalopathy.

Authors:  L Zieve
Journal:  Metab Brain Dis       Date:  1987-09       Impact factor: 3.584

3.  Prognostic value of the oculovestibular reflex in fulminant hepatic failure.

Authors:  M A Hanid; D B Silk; R Williams
Journal:  Br Med J       Date:  1978-04-22

4.  Kinetics of 14C-glycocholic acid clearance in normal man and in patients with liver disease.

Authors:  I T Gilmore; R P Thompson
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

5.  Determinants of fasting and postprandial serum bile acid levels in healthy man.

Authors:  N F LaRusso; N E Hoffman; M G Korman; A F Hofmann; A E Cowen
Journal:  Am J Dig Dis       Date:  1978-05

6.  Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.

Authors:  A F Hofmann; G Molino; M Milanese; G Belforte
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

Review 7.  Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring.

Authors:  D R Dufour; J A Lott; F S Nolte; D R Gretch; R S Koff; L B Seeff
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

Review 8.  Cholyllysyl fluroscein and related lysyl fluorescein conjugated bile acid analogues.

Authors:  C O Mills; P Milkiewicz; V Saraswat; E Elias
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.